|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
258,990,000 |
Market
Cap: |
19.33(B) |
Last
Volume: |
1,107,186 |
Avg
Vol: |
1,900,163 |
52
Week Range: |
$65.11 - $82.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 317 |
Guru Rank Value : 4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
26,945 |
67,902 |
123,113 |
368,767 |
Total Sell Value |
$2,043,551 |
$5,004,391 |
$8,902,469 |
$27,563,219 |
Total People Sold |
3 |
4 |
6 |
10 |
Total Sell Transactions |
3 |
6 |
8 |
16 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Garrett Scott T |
Director |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
65,574 |
|
- |
|
Crawford Sally |
Director |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
129,890 |
|
- |
|
Dockendorff Charles J |
Director |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
5,260 |
|
- |
|
Nawana Namal |
Director |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
16,756 |
|
- |
|
Daugherty Sean S. |
Group President, BSH & Surg. |
|
2022-02-24 |
4 |
S |
$71.14 |
$155,016 |
D/D |
(2,179) |
49,091 |
|
0% |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2021-11-12 |
4 |
D |
$73.54 |
$6,749,281 |
D/D |
(91,777) |
2,355,893 |
|
- |
|
Griffin John M. |
General Counsel |
|
2021-11-12 |
4 |
D |
$73.54 |
$969,551 |
D/D |
(13,184) |
157,602 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2021-11-12 |
4 |
D |
$73.54 |
$149,066 |
D/D |
(2,027) |
70,691 |
|
- |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2021-11-12 |
4 |
D |
$73.54 |
$502,499 |
D/D |
(6,833) |
60,075 |
|
- |
|
Daugherty Sean S. |
Group President, BSH & Surg. |
|
2021-11-12 |
4 |
D |
$73.54 |
$471,097 |
D/D |
(6,406) |
51,270 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2021-11-12 |
4 |
D |
$73.54 |
$21,547 |
D/D |
(293) |
18,174 |
|
- |
|
Hellmann Elisabeth A |
SVP, Human Resources |
|
2021-11-12 |
4 |
D |
$73.54 |
$20,738 |
D/D |
(282) |
8,292 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2021-11-11 |
4 |
D |
$72.61 |
$66,220 |
D/D |
(912) |
105,939 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2021-11-11 |
4 |
D |
$72.61 |
$533,320 |
D/D |
(7,345) |
2,447,670 |
|
- |
|
Griffin John M. |
General Counsel |
|
2021-11-11 |
4 |
D |
$72.61 |
$94,175 |
D/D |
(1,297) |
170,786 |
|
- |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2021-11-11 |
4 |
D |
$72.61 |
$45,890 |
D/D |
(632) |
66,908 |
|
- |
|
Daugherty Sean S. |
Group President, BSH & Surg. |
|
2021-11-11 |
4 |
D |
$72.61 |
$40,371 |
D/D |
(556) |
57,676 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2021-11-11 |
4 |
D |
$72.61 |
$23,380 |
D/D |
(322) |
18,467 |
|
- |
|
Hellmann Elisabeth A |
SVP, Human Resources |
|
2021-11-11 |
4 |
D |
$72.61 |
$20,694 |
D/D |
(285) |
8,574 |
|
- |
|
Griffin John M. |
General Counsel |
|
2021-11-09 |
4 |
D |
$71.26 |
$65,488 |
D/D |
(919) |
172,083 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2021-11-09 |
4 |
D |
$71.26 |
$48,457 |
D/D |
(680) |
106,851 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2021-11-09 |
4 |
D |
$71.26 |
$22,091 |
D/D |
(310) |
72,718 |
|
- |
|
Daugherty Sean S. |
Group President, BSH & Surg. |
|
2021-11-09 |
4 |
D |
$71.26 |
$33,421 |
D/D |
(469) |
58,232 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2021-11-09 |
4 |
D |
$71.26 |
$15,321 |
D/D |
(215) |
18,789 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2021-11-09 |
4 |
D |
$71.26 |
$297,368 |
D/D |
(4,173) |
2,455,015 |
|
- |
|
1698 Records found
|
|
Page 7 of 68 |
|
|